Heart failure & cardiomyopathies

Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac Amyloidosis

JACC Cardiovasc ImagingPublished Diagnostic accuracy study

Authors' conclusion

The authors' detection model is effective at identifying patients with cardiac uptake Perugini grade ≥2 on WBS and may help in the diagnosis of patients with cardiac amyloidosis.

Study context

Population
Technetium-99m whole-body scintigraphies (whole-body scintigraphy (WBS)) from hospital databases; detection of significant cardiac uptake (Perugini grade ≥2) to retrieve patients at risk of cardiac amyloidosisimages
Participants
3,048 vs 1,633
Comparison
5-fold cross-validation vs External validation
  • 5-fold cross-validationn = 3,048
  • External validationn = 1,633
Outcome
Performance (C-statistics: sensitivity, specificity, AUC) of a deep learning model (convolutional neural network) detecting cardiac uptake Perugini grade ≥2 on WBS
Methodological details5-fold cross-validation, external validation
  • 5-fold cross-validation
  • External validation

Performance

As reported in the abstract

Detection of cardiac uptake Perugini grade ≥2
Test or modelAUCSensitivitySpecificity
5-fold cross-validation0.999 (SD = 0.000)98.9% (± 1.0)99.5% (± 0.4)
External validation0.99996.1%99.5%

AUC

5-fold cross-validation0.999 (SD = 0.000)
External validation0.999

Sensitivity

5-fold cross-validation98.9% (± 1.0)
External validation96.1%

Specificity

5-fold cross-validation99.5% (± 0.4)
External validation99.5%

Further findings

Performance by sex, age <90 years, BMI, injection-acquisition delay, radionuclides and WBS indication

Only slightly affected performances

Original publication

Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac Amyloidosis. JACC Cardiovasc Imaging. Published 12 April 2023. doi:10.1016/j.jcmg.2023.01.014

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.